Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Momentum Trial: The Efficacy of Using a Smartphone Application to Support Shared Decision Making Through Patient Activation in People With a Diagnosis of Schizophrenia in Outpatient Treatment Settings
Brief Summary: This study investigates the effects of using a smartphone app to support shared decision making (SDM) for people with schizophrenia-spectrum disorders in an outpatient treatment setting. Patients are randomized to specialized early intervention treatment with the Momentum app or without the app. The primary objective is to investigate the effect of the app on patient activation 6 months after baseline. Secondary outcomes are positive and negative symptoms, level of functioning; working alliance; self-efficacy; treatment satisfaction; hope; level of SDM; and perceived efficacy in patient-provider interaction. Explorative outcomes are self-perceived usefulness of the Momentum app.


Options:
A: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: paliperidone palmitate | Arm Label: 002; Type: ACTIVE_COMPARATOR; Interventions: Drug: aripiprazole | Arm Label: 003; Type: ACTIVE_COMPARATOR; Interventions: Drug: haloperidole | Arm Label: 004; Type: ACTIVE_COMPARATOR; Interventions: Drug: olanzapine | Arm Label: 005; Type: ACTIVE_COMPARATOR; Interventions: Drug: paliperidone | Arm Label: 006; Type: ACTIVE_COMPARATOR; Interventions: Drug: perphenazine | Arm Label: 007; Type: ACTIVE_COMPARATOR; Interventions: Drug: quetiapine | Arm Label: 008; Type: ACTIVE_COMPARATOR; Interventions: Drug: risperidone | Intervention Type: DRUG; Name: paliperidone; Assigned to Arm(s): 005 | Intervention Type: DRUG; Name: risperidone; Assigned to Arm(s): 008 | Intervention Type: DRUG; Name: haloperidole; Assigned to Arm(s): 003 | Intervention Type: DRUG; Name: perphenazine; Assigned to Arm(s): 006 | Intervention Type: DRUG; Name: aripiprazole; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: quetiapine; Assigned to Arm(s): 007 | Intervention Type: DRUG; Name: paliperidone palmitate; Assigned to Arm(s): 001 | Intervention Type: DRUG; Name: olanzapine; Assigned to Arm(s): 004
B: Arm Label: Intervention: Momentum app; Type: EXPERIMENTAL; Interventions: Device: Momentum app | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Momentum app; Assigned to Arm(s): Intervention: Momentum app
C: Arm Label: Method Guided Self-Determination; Type: EXPERIMENTAL; Interventions: Behavioral: Guided Self-Determination GSD | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Guided Self-Determination GSD; Assigned to Arm(s): Method Guided Self-Determination
D: Arm Label: RQP-MH; Type: EXPERIMENTAL; Interventions: Behavioral: Right Question Project - Mental Health (RQP-MH) | Arm Label: Comparison Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Pamphlet | Intervention Type: BEHAVIORAL; Name: Right Question Project - Mental Health (RQP-MH); Assigned to Arm(s): RQP-MH | Intervention Type: BEHAVIORAL; Name: Pamphlet; Assigned to Arm(s): Comparison Group

Answer: B